Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation.

Cureus · 2016 · PMC5115842 · PMID 27900231

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

NRS data indicated that DOACs (dabigatran, 110 mg and 150 mg, and rivaroxaban) showed a trend toward a smaller risk of ischemic stroke than warfarin with more benefit in the older elderly than the younger elderly (RRs range: 0.85 - 0.85 and 0.76 - 0.81, respectively) [ 9 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.